16-546972-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005632.3(CAPN15):āc.134A>Gā(p.Glu45Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,610,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000059 ( 0 hom., cov: 34)
Exomes š: 0.0000069 ( 0 hom. )
Consequence
CAPN15
NM_005632.3 missense
NM_005632.3 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 5.85
Genes affected
CAPN15 (HGNC:11182): (calpain 15) This gene encodes a protein containing zinc-finger-like repeats and a calpain-like protease domain. The encoded protein may function as a transcription factor, RNA-binding protein, or in protein-protein interactions during visual system development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11717427).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN15 | NM_005632.3 | c.134A>G | p.Glu45Gly | missense_variant | 4/14 | ENST00000219611.7 | NP_005623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN15 | ENST00000219611.7 | c.134A>G | p.Glu45Gly | missense_variant | 4/14 | 1 | NM_005632.3 | ENSP00000219611.2 | ||
CAPN15 | ENST00000637507.1 | c.338A>G | p.Glu113Gly | missense_variant | 2/2 | 5 | ENSP00000490480.1 | |||
CAPN15 | ENST00000562370.5 | c.134A>G | p.Glu45Gly | missense_variant | 3/3 | 2 | ENSP00000456017.1 | |||
CAPN15 | ENST00000568988.5 | c.-314-587A>G | intron_variant | 3 | ENSP00000457030.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152120Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
10
AN:
152120
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000325 AC: 8AN: 245794Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134216
GnomAD3 exomes
AF:
AC:
8
AN:
245794
Hom.:
AF XY:
AC XY:
4
AN XY:
134216
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1458034Hom.: 0 Cov.: 32 AF XY: 0.00000551 AC XY: 4AN XY: 725512
GnomAD4 exome
AF:
AC:
10
AN:
1458034
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
725512
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152238Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74456
GnomAD4 genome
AF:
AC:
9
AN:
152238
Hom.:
Cov.:
34
AF XY:
AC XY:
5
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2024 | The c.134A>G (p.E45G) alteration is located in exon 4 (coding exon 1) of the CAPN15 gene. This alteration results from a A to G substitution at nucleotide position 134, causing the glutamic acid (E) at amino acid position 45 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Pathogenic
D;D;.
Polyphen
1.0
.;D;.
Vest4
0.43
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at